Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mismetti

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysisJ C Trone, E Ollier, C Chapelle, et al.
Heart (British Cardiac Society)|April 16, 2015
Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysisF Hourcade-Potelleret, S Laporte, V Lehnert, et al.
The European Respiratory Journal|October 1, 1996
Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive casesB Tardy, P Mismetti, Y Page, et al.
Thrombosis and Haemostasis|August 1, 1995
Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteersP Mismetti, J Reynaud, B Tardy-Ponce, et al.
Respiratory Medicine and Research|September 19, 2019
Chronic thromboembolic pulmonary hypertension suspicion after pulmonary embolism in cancer patientsJ Catella-Chatron, A Merah, E De Magalhaes, et al.
Fundamental & Clinical Pharmacology|November 18, 1998
Pharmacokinetic and pharmacodynamic variations of acenocoumarol orally administrated either once or twice daily in patients with deep venous thrombosisP Mismetti, J Reynaud, S Laporte-Simitsidis, et al.
Therapie|March 4, 2003
[Prevention of thrombosis during pregnancy: from recommendations to practice from 26 cases]M Epinat, A Buchmüller-Cordier, D Delsart, et al.
Journal of Thrombosis and Haemostasis : JTH|January 15, 2011
Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patientsS Laporte, J Liotier, L Bertoletti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
Fibrinolysis and elastic compression: no fibrinolytic effect of elastic compression in healthy volunteersP Conchonnet, P Mismetti, J Reynaud, et al.
Thrombosis and Haemostasis|June 27, 2014
Indirect comparison meta-analysis of two enoxaparin regimens in patients undergoing major orthopaedic surgery. Impact on the interpretation of thromboprophylactic effects of new anticoagulant drugsS Laporte, C Chapelle, L Bertoletti, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysisJ C Trone, E Ollier, C Chapelle, et al.
Heart (British Cardiac Society)|April 16, 2015
Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysisF Hourcade-Potelleret, S Laporte, V Lehnert, et al.
The European Respiratory Journal|October 1, 1996
Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive casesB Tardy, P Mismetti, Y Page, et al.
Thrombosis and Haemostasis|August 1, 1995
Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteersP Mismetti, J Reynaud, B Tardy-Ponce, et al.
Respiratory Medicine and Research|September 19, 2019
Chronic thromboembolic pulmonary hypertension suspicion after pulmonary embolism in cancer patientsJ Catella-Chatron, A Merah, E De Magalhaes, et al.
Fundamental & Clinical Pharmacology|November 18, 1998
Pharmacokinetic and pharmacodynamic variations of acenocoumarol orally administrated either once or twice daily in patients with deep venous thrombosisP Mismetti, J Reynaud, S Laporte-Simitsidis, et al.
Therapie|March 4, 2003
[Prevention of thrombosis during pregnancy: from recommendations to practice from 26 cases]M Epinat, A Buchmüller-Cordier, D Delsart, et al.
Journal of Thrombosis and Haemostasis : JTH|January 15, 2011
Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patientsS Laporte, J Liotier, L Bertoletti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
Fibrinolysis and elastic compression: no fibrinolytic effect of elastic compression in healthy volunteersP Conchonnet, P Mismetti, J Reynaud, et al.
Thrombosis and Haemostasis|June 27, 2014
Indirect comparison meta-analysis of two enoxaparin regimens in patients undergoing major orthopaedic surgery. Impact on the interpretation of thromboprophylactic effects of new anticoagulant drugsS Laporte, C Chapelle, L Bertoletti, et al.
Pageof 11